Netherlands Diabetes Market, Size, Forecast 2023-2028, Industry Trends, Growth, Impact of Inflation, Opportunity Company Analysis
Netherlands Diabetes Market
Netherlands Diabetes Market will reach US$ 3.36 Billion in 2028 according to Renub Research. Diabetes is a chronic, life-threatening disease with no available cure. According to IDF Europe, there are more than 60 million diabetic people in the European Region; by 2045, this number will rise by 13%. In the Netherlands, the prevalence of diabetes mellitus (DM) is increasing rapidly. Netherlands' care for diabetes mainly concentrates on primary health care, with responsibility for most aspects of care in the hands of general practitioners.
Generally, primary health care in The Netherlands provides a good standard of care for subjects with diabetes mellitus. Another point of concern is the rise in the prevalence of obesity, leading to a vast increase in subjects with metabolic syndrome. Therefore, DM (diabetes mellitus) care and its provision will play an essential role in health care in The Netherlands.
Type 2 Diabetes will grow due to the rise in the Prevalence of Obesity
The Netherlands has observed a rise in the prevalence of type 2 diabetes during the last decade. This rise is due to the aging of Dutch population, and the incidence of obesity as a significant risk factor for diabetes is increasing; and multiple screening initiatives are being implemented. Netherlands Diabetes Industry was valued at US$ 2.62 Billion in 2022.
According to the IDF, in 2019, 463 million people worldwide had diabetes, of whom approximately 1.1 million have type1. In the Netherlands, about 1.2 million people have diabetes, of which about 10% have type 1 diabetes. The factors that lead to type 1 diabetes can be both genetic and viral. In addition, the rise in the prevalence of weight gain also contributes to the increase in the disease.
Insulin Pen is predicted to grow at a significant rate during the Forecast Period
The Netherlands Market is segmented into Self Monitoring Blood Glucose Device, Continuous Glucose Monitoring Devices, Insulin Pumps, and Insulin Pens. The prevalence of diabetes is increasing among all ages in the Netherlands, primarily due to increase in overweight and obesity, unhealthy diet, and physical inactivity. Therefore, the demand and market for insulin pens are increasing in the Netherlands. The rise is due to the availability of reimbursement of insulin pens and an increase in the diabetic population.
Netherlands Diabetes Industry to expand at a CAGR of 4.23% from 2023 to 2028
The numbers of factors contributing to the high market share of insulin pumps in the Netherlands are as follows
The growing aging population.
Increasing prevalence of diabetes.
Rising awareness regarding the benefits of the insulin pump.
High per capita disposable income.
Advanced diabetes infrastructure.
In addition, the gradual advancement of insulin pumps and their growing adoption among diabetes patients over conventional techniques are opening solid opportunities for the insulin pump market in the Netherlands.
Government Initiatives
The National Action program Diabetes (NAD) implementation in the Netherlands over the past decade has helped manage diabetes. It aims to inaugurate the Care Standard (CS) for diabetes using a particular implementation plan and to pilot it in several regions. For instance, Roche got CE Mark for its Accu-ChekSugarView app. Accu-ChekSugarView, the first app that examines blood glucose ranges by taking pictures with a Smartphone camera without requiring a blood glucose meter, in December 2019. Moreover, in 2018, The National Prevention Agreement was approved and set out ambitious goals to make the Netherlands healthier by 2040.
Key Players:
The Netherlands Diabetes Market comprises major manufacturers, B. Braun Melsungen AG, Eli Lilly and Company, Terumo Corporation, Becton, Dickinson (BD), Novo Nardisk, Ypsomed AG, Medtronic, Insulet Corporations, Abbott Laboratories, DarioHealth Crop, Dexcom, Inc, Roche Diagnostic, Tandem Diabetes Care.
- In May 2021, Medtronic secured European approvals for its Guardian 4 sensor. The Guardian 4 sensor can be either utilized as a standalone continuous glucose monitor or combined into Medtronic's insulin pumps and pens to add real-time glucose monitoring alongside insulin tracking.
Renub Research report titled “Netherlands Diabetes Market & Forecast, By Continuous Glucose Monitoring (CGM Market by Components, Glucose Sensor, Transmitter, CGM User, Reimbursement), Self-Monitoring Blood Glucose (SMBG Market by, Test Strips, Lancet, Meter, Blood Glucose Device Users & Reimbursement), Insulin Pen (User, Types – Disposable, Reusable and Smart Insulin Pen, Insulin Pen Needle Market, Reimbursement Policies), Insulin Pump (Users, Market & Differentiation Points of Insulin Pump Products, Training Model for Patients & HCP, Reimbursement Policies) Company (B. Braun Melsungen AG, Eli Lilly and Company, Terumo Corporation, Becton, Dickinson (BD), Novo Nardisk, Ypsomed AG, Medtronic, Insulet Corporations, Abbott Laboratories, DarioHealth Crop, Dexcom, Inc, Roche Diagnostic, Tandem Diabetes Care)” provides a complete analysis of the Netherlands Diabetes Market.
Segments Market based on Devices
1. Continuous Glucose Monitoring (CGM)
2. Self-Monitoring Blood Glucose (SMBG)
3. Insulin Pen
4. Insulin Pump
The Netherlands Diabetes Sub-Segment Analysis
1. Continuous Glucose Monitoring (CGM) – Market breakup from four viewpoints
1. Glucose Sensor Market & Forecast
2. CGM Transmitter Market & Forecast
3. CGM User
4. CGM Reimbursement
2. SMBG – Market breakup from five viewpoints
1. Test Strips Market and Forecast
2. Lancet Market and Forecast
3. Meter Market and Forecast
4. Blood Glucose (SMBG) Users
5. Blood Glucose Devices Reimbursement
3. Insulin Pen Market – Market breakup from six viewpoints
1. Disposable Insulin Pen
2. Reusable Insulin Pen
3. Smart Insulin Pen
4. Insulin Pen Needle Market
5. Insulin Pen Users
6. Reimbursement Policies
4. Insulin Pump Market – Market breakup from four viewpoints
1. Insulin Pump Market
2. Insulin Pump Users
3. Insulin Pump Products
4. Reimbursement Policies
All the 13 Companies Studied in the Report have been Studied from 3 Points
• Company Overview
• Recent Developments
• Financial Insight
Company Analysis
1. B. Braun Melsungen AG
2. Eli Lilly and Company
3. Terumo Corporation
4. Becton, Dickinson (BD)
5. Novo Nardisk,
6. Ypsomed AG
7. Medtronic
8. Insulet Corporation
9. Abbott Laboratories
10. DarioHealth Crop
11. Dexcom, Inc
12. Roche Diagnostic
13. Tandem Diabetes Care
Report Details:
| Report Features | Details |
| Base Year | 2022 |
| Historical Period | 2017 - 2022 |
| Forecast Period | 2023 - 2028 |
| Market | US$ Billion |
| Segment Covered | CGM, SMBG, Insulin Pen, and Insulin Pump |
| Companies Covered | B. Braun Melsungen AG, Eli Lilly and Company, Terumo Corporation, Becton, Dickinson (B.D.), Novo Nordisk, Ypsomed AG, Medtronic, Insulet Corporations, Abbott Laboratories, DarioHealth Crop, Dexcom, Inc, Roche Diagnostic, and Tandem Diabetes Care |
| Customization Scope | 20% Free Customization |
| Post-Sale Analyst Support | 1 Year (52 Weeks) |
| Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on request) |
Frequently Asked Questions (FAQ): This report provides current market estimates and forecasts for NetherlandsDiabetic Market.
- Detailed analysis of the key market segments such as source, geography and applications; provides a comprehensive understanding of the market.
- Detailed analysis of Netherlands SMBG Market.
- Detailed analysis of Netherlands CGM Market.
- Detailed analysis of Netherlands Insulin Pump Market.
- Detailed analysis of Netherlands Insulin Pen Market.
- Netherlands Diabetic Market – Growth Drivers and Challenges.
- Key sustainability strategies adopted by market players.
1. Introduction
2. Research Methodology
3. Executive Summary
4. Market Dynamics
4.1 Growth Drivers
4.2 Challenges
5. Netherlands Diabetes Market
6. Netherlands Diabetes Population
6.1 Type 1 Diabetes
6.2 Type 2 Diabetes
7. Market Share – Netherlands Diabetes Market
7.1 By Types
8. Continuous Glucose Monitoring Market (CGM) – Netherlands Market & Users
8.1 Netherlands - CGM Market by Components
8.1.1 Glucose Sensor Market & Forecast
8.1.2 CGM Transmitter Market & Forecast
8.2 Netherlands – CGM User
8.3 CGM Reimbursement in Netherlands
9. Blood Glucose Device (SMBG) – Netherlands Market & Users
9.1 Market
9.1.1 Type 1 Diabetes
9.1.2 Type 2 Diabetes
9.2 Test Strips Market
9.2.1 Type 1 Diabetes
9.2.2 Type 2 Diabetes
9.3 Lancet Market
9.3.1 Type 1 Diabetes
9.3.2 Type 2 Diabetes
9.4 Meter Market and Forecast
9.4.1 Type 1 Diabetes
9.4.2 Type 2 Diabetes
9.5 Blood Glucose (SMBG) Users
9.5.1 Type 1 Diabetes
9.5.2 Type 2 Diabetes
9.6 Reimbursement of Blood Glucose Devices inNetherlands
10. Insulin Pen - Netherlands Market & User
10.1 Insulin Pen Market
10.1.1 Disposable Insulin Pen Market
10.1.2 Reusable Insulin Pen Market
10.1.3 Smart Insulin Pen Market
10.2 Insulin Pen User
10.2.1 Disposable Insulin Pen User
10.2.2 Reusable Insulin Pen User
10.2.3 Smart Insulin Pen User
10.3 Insulin Pen Needle Market
10.4 Reimbursement Policies
11. Insulin Pump - Netherlands Market & Users
11.1 Insulin Pump Market
11.1.1 Type 1 Insulin Pump Market
11.1.2 Type 2 Insulin Pump Market
11.2 Insulin Pump User
11.2.1 Type 1 Insulin Pump User
11.2.2 Type 2 Insulin Pump User
11.3 Differentiation Points of Insulin Pump Products in Netherlands
11.3.1 Animas Vibe
11.3.2 Medtronic 530G with Enlite
11.3.3 InsuletOmniPod
11.3.4 Tandem t: slim
11.3.5 Roche Accu-Chek Combo
11.4 Training Model for Patients & HCP – of Medtronic, Animas, Insulet Corp & Tandem Diabetes Care
11.4.1 Medtronic
11.5 Insulet Corporation
11.5.1 Training Structure for New Patients - Insulet Corporation
11.6 Animas Corporation
11.6.1 Training Modules for New Patients
11.6.2 Training Modules for HCP (Health Care Professional)
11.7 Tandem Diabetes Care
11.8 Reimbursement Policies on Insulin Pump
12. Insulin Pen – Company Analysis
12.1 B. Braun Melsungen AG
12.1.1 Overview
12.1.2 Recent Development
12.1.3 Revenue
12.2 Eli Lilly
12.2.1 Overview
12.2.2 Recent Development
12.2.3 Revenue
12.3 Terumo Corporation
12.3.1 Overview
12.3.2 Recent Development
12.3.3 Revenue
12.4 BD
12.4.1 Overview
12.4.2 Recent Development
12.4.3 Revenue
12.5 Novo Nordisk A/S
12.5.1 Overview
12.5.2 Recent Development
12.5.3 Revenue
12.6 Ypsomed AG
12.6.1 Overview
12.6.2 Recent Development
12.6.3 Revenue
13. Insulin Pump – Company Analysis
13.1 Medtronic
13.1.1 Overview
13.1.2 Recent Development
13.1.3 Revenue
14. SMBG – Company Analysis
14.1 DarioHealth Corp
14.1.1 Overview
14.1.2 Recent Development
14.1.3 Revenue
14.2 Abbott Laboratories
14.2.1 Overview
14.2.2 Recent Development
14.2.3 Revenue
15. CGM – Company Analysis
15.1 Dexcom Inc
15.1.1 Overview
15.1.2 Recent Development
15.1.3 Revenue
15.2 Roche
15.2.1 Overview
15.2.2 Recent Development
15.2.3 Revenue
15.3 Tandem Diabetes Care
15.3.1 Overview
15.3.2 Recent Development
15.3.3 Revenue
List of Figures:
Figure-01: Netherlands – Diabetes Market (Billion US$), 2017 – 2022
Figure-02: Netherlands – Forecast for Diabetes Market (Billion US$), 2023 – 2028
Figure-03: Netherlands – Type 1 Diabetes Population (Thousand), 2017 – 2022
Figure-04: Netherlands – Forecast for Type 1 Diabetes Population (Thousand), 2023 – 2028
Figure-05: Netherlands – Type 2 Diabetes Population (Thousand), 2017 – 2022
Figure-06: Netherlands – Forecast for Type 2 Diabetes Population (Thousand), 2023 – 2028
Figure-07: Netherlands – Glucose Sensor Market Market (Million US$), 2017 – 2023
Figure-08: Netherlands – Forecast for Glucose Sensor Market Market (Million US$), 2023 – 2028
Figure-09: Netherlands – CGM Transmitter Market Market (Million US$), 2017 – 2023
Figure-10: Netherlands – Forecast for CGM Transmitter Market Market (Million US$), 2023 – 2028
Figure-11: Netherlands – CGM User (Thousand), 2017 – 2023
Figure-12: Netherlands – Forecast for CGM User (Thousand),2023 – 2028
Figure-13: Netherlands – Self-Monitoring of Blood Glucose (SMBG) Type 1 Diabetes Market (Million US$), 2023 – 2028
Figure-14: Netherlands – Forecast for Self-Monitoring of Blood Glucose (SMBG) Type 1 Diabetes Market (Million US$), 2017 – 2023
Figure-15: Netherlands – Self-Monitoring of Blood Glucose (SMBG) Type 2 Diabetes Market (Million US$), 2023 – 2028
Figure-16: Netherlands – Forecast for Self-Monitoring of Blood Glucose (SMBG) Type 2 Diabetes Market (Million US$), 2017 – 2023
Figure-17: Netherlands – Test Strips Type 1 Diabetes Market (Million US$), 2023 – 2028
Figure-18: Netherlands – Forecast for Test Strips Type 1 Diabetes Market (Million US$), 2017 – 2023
Figure-19: Netherlands – Test Strips Type 2 Diabetes Market (Million US$), 2023 – 2028
Figure-20: Netherlands – Forecast for Test Strips Type 2 Diabetes Market (Million US$), 2017 – 2023
Figure-21: Netherlands – Lancet Type 1 Diabetes Market (Million US$), 2023 – 2028
Figure-22: Netherlands – Forecast for Lancet Type 1 Diabetes Market (Million US$), 2017 – 2023
Figure-23: Netherlands – Lancet Type 2 Diabetes Market (Million US$), 2023 – 2028
Figure-24: Netherlands – Forecast for Lancet Type 2 Diabetes Market (Million US$), 2017 – 2023
Figure-25: Netherlands – Meter Type 1 Diabetes Market (Million US$), 2023 – 2028
Figure-26: Netherlands – Forecast for Meter Type 1 Diabetes Market (Million US$), 2017 – 2023
Figure-27: Netherlands – Meter Type 2 Diabetes Market (Million US$), 2023 – 2028
Figure-28: Netherlands – Forecast for Meter Type 2 Diabetes Market (Million US$), 2017 – 2023
Figure-29: Netherlands – Self-Monitoring of Blood Glucose (SMBG) Type 1 Users (Thousand), 2017 – 2022
Figure-30: Netherlands – Forecast for Self-Monitoring of Blood Glucose (SMBG) Type 1 Users (Thousand), 2023 – 2028
Figure-31: Netherlands – Self-Monitoring of Blood Glucose (SMBG) Type 2 Users (Thousand), 2017 – 2022
Figure-32: Netherlands – Forecast for Self-Monitoring of Blood Glucose (SMBG) Type 2 Users (Thousand), 2023 – 2028
Figure-33: Netherlands – Disposable Insulin Pen Market (Million US$), 2017 – 2023
Figure-34: Netherlands – Forecast for Disposable Insulin Pen Market (Million US$), 2023 – 2028
Figure-35: Netherlands – Reusable Insulin Pen Market (Million US$), 2017 – 2023
Figure-36: Netherlands – Forecast for Reusable Insulin Pen Market (Million US$), 2023 – 2028
Figure-37: Netherlands – Smart Insulin Pen Market (Million US$), 2017 – 2023
Figure-38: Netherlands – Forecast for Smart Insulin Pen Market (Million US$), 2023 – 2028
Figure-39: Netherlands – Disposable Insulin Pen User (Thousand), 2017 – 2022
Figure-40: Netherlands – Forecast for Disposable Insulin Pen User (Thousand), 2023 – 2028
Figure-41: Netherlands – Reusable Insulin Pen User (Thousand), 2017 – 2022
Figure-42: Netherlands – Forecast for Reusable Insulin Pen User (Thousand), 2023 – 2028
Figure-43: Netherlands – Smart Insulin Pen User (Thousand), 2017 – 2022
Figure-44: Netherlands – Forecast for Smart Insulin Pen User (Thousand), 2023 – 2028
Figure-45: Netherlands – Insulin Pen Needle Market Market (Million US$), 2017 – 2023
Figure-46: Netherlands – Forecast for Pen Needle Market Market (Million US$), 2023 – 2028
Figure-47: Netherlands – Insulin Pump Market for Type 1 Diabetes Market (Million US$), 2017 – 2023
Figure-48: Netherlands – Forecast for Insulin Pump Market for Type 1 Diabetes Market (Million US$), 2023 – 2028
Figure-49: Netherlands – Insulin Pump Market for Type 2 Diabetes Market (Million US$), 2017 – 2023
Figure-50: Netherlands – Forecast for Insulin Pump Market for Type 2 Diabetes Market (Million US$), 2023 – 2028
Figure-51: Netherlands – Insulin Pump Type 1 Users (Thousand), 2017 – 2022
Figure-52: Netherlands – Forecast for Insulin Pump Type 1 Users (Thousand), 2023 – 2028
Figure-53: Netherlands – Insulin Pump Type 2 Users (Thousand), 2017 – 2022
Figure-54: Netherlands – Forecast for Insulin Pump Type 2 Users (Thousand), 2023 – 2028
Figure-55: B. Braun Melsungen AG – Global Revenue (Billion US$), 2017 – 2022
Figure-56: B. Braun Melsungen AG – Forecast for Global Revenue (Billion US$), 2023 – 2028
Figure-57: Eli Lilly – Global Revenue (Billion US$), 2017 – 2022
Figure-58: Eli Lilly – Forecast for Global Revenue (Billion US$), 2023 – 2028
Figure-59: Terumo Corporation – Global Revenue (Billion US$), 2017 – 2022
Figure-60: Terumo Corporation – Forecast for Global Revenue (Billion US$), 2023 – 2028
Figure-61: BD – Global Revenue (Billion US$), 2017 – 2022
Figure-62: BD – Forecast for Global Revenue (Billion US$), 2023 – 2028
Figure-63: Novo Nordisk A/S – Global Revenue (Billion US$), 2017 – 2022
Figure-64: Novo Nordisk A/S – Forecast for Global Revenue (Billion US$), 2023 – 2028
Figure-65: Ypsomed AG – Global Revenue (Billion US$), 2017 – 2022
Figure-66: Ypsomed AG – Forecast for Global Revenue (Billion US$), 2023 – 2028
Figure-67: Medtronic – Global Revenue (Billion US$), 2017 – 2022
Figure-68: Medtronic – Forecast for Global Revenue (Billion US$), 2023 – 2028
Figure-69: Insulet Corporation – Global Revenue (Billion US$), 2017 – 2022
Figure-70: Insulet Corporation – Forecast for Global Revenue (Billion US$), 2023 – 2028
Figure-71: DarioHealth Corp – Global Revenue (Billion US$), 2017 – 2022
Figure-72: DarioHealth Corp – Forecast for Global Revenue (Billion US$), 2023 – 2028
Figure-73: Abbott Laboratories – Global Revenue (Billion US$), 2017 – 2022
Figure-74: Abbott Laboratories – Forecast for Global Revenue (Billion US$), 2023 – 2028
Figure-75: Dexcom Inc – Global Revenue (Billion US$), 2017 – 2022
Figure-76: Dexcom Inc – Forecast for Global Revenue (Billion US$), 2023 – 2028
Figure-77: Roche – Global Revenue (Billion US$), 2017 – 2022
Figure-78: Roche – Forecast for Global Revenue (Billion US$), 2023 – 2028
Figure-79: Tandem Diabetes Care – Global Revenue (Billion US$), 2017 – 2022
Figure-80: Tandem Diabetes Care – Forecast for Global Revenue (Billion US$), 2023 – 2028
List of Tables:
Table-01: Netherlands – Diabetes Market Share by Type (Percent), 2017 – 2022
Table-02: Netherlands – Forecast for Diabetes Market Share by Type (Percent), 2023 – 2028
Reach out to us
Call us on
USA: +1-678-302-0700
INDIA: +91-120-421-9822
Drop us an email at
info@renub.com